MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02545nam a22003257a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
OB 2021 0001 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
PILC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240720153244.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220427b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Language of cataloging |
eng |
| Transcribing agency |
FEU-NRMF MEDICAL LIBRARY |
| Description conventions |
rda |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
english |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
OB 2021 0001 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Comparison of the effect of miconazole and clotrimazole in the treatment of vulvovaginal candidiasis among women seen in a tertiary medical center from 2016 to 2020 / |
| Statement of responsibility, etc. |
Shiara Marriz Marquez; Lylah Reyes. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Fairview, Quezon City: |
| Name of publisher, distributor, etc. |
Department of Obstetrics and Gynecology, FEU-NRMF, |
| Date of publication, distribution, etc. |
2021. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
29 pages: |
| Other physical details |
tables; |
| Dimensions |
(in folder) + |
| Accompanying material |
with flash drive (soft copy). |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes appendices and bibliographical references. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Abstract: Vulvovaginal candidiasis (VVC) is one of the frequent infections of the female genital tract and is the second most common cause of vaginal infections after bacterial vaginosis. According to the Center for Disease Control and Prevention (CDC), azoles are the first-line of treatment for VVC. Among the azoles available in the Philippines, only miconazole and clotrimazole are recommended for both pregnant and non-pregnant women. This study reviewed a total of 316 records of patients, regardless of pregnancy status who were given either single dose 1200 mg miconazole or a 6-day 100 mg clotrimazole vaginal suppository and treatment for vulvovaginal candidiasis. Upon follow-up, 11 out of 316 (3.46%) were still symptomatic which was noted in 2 (18.1%) from the miconazole group while 9 (81.8%) from the clotrimazole group. The difference for these outcome between the treatment groups is statistically significant. With regards to treatment failure rate, for miconazole it is 1.2% (2/161) while for clotrimazole, it is 5.8% (9/155). None of the charts of these women had recorded adverse reaction to the given treatment. In conclusion, the single-dose miconazole regimen has a significant higher clinical cure rate than the 6-day clotrimazole. It has the potential to improve patient compliance and improve treatment outcome at a lower cost. |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
Research - Department of Obstetrics & Gynecology |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
vulvovaginal candidiasis |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
miconazole |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
clotrimasole |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
azole antifungals |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
vaginitis |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Marquez, Shiara Marriz, MD. |
| Relator term |
principal investigator |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Reyes, Lylah, MD. |
| Relator term |
co-author |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Room Use |
